Page last updated: 2024-08-21

thymidine monophosphate and Endometrial Neoplasms

thymidine monophosphate has been researched along with Endometrial Neoplasms in 1 studies

*Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dai, T; Duan, Y; Li, C; Liu, W; Man, Y; Niu, F; Wei, D; Zhang, H1

Other Studies

1 other study(ies) available for thymidine monophosphate and Endometrial Neoplasms

ArticleYear
Mitochondrial protein LETM1 and its-mediated CTMP are potential therapeutic targets for endometrial cancer.
    Anti-cancer drugs, 2022, 08-01, Volume: 33, Issue:7

    Topics: Animals; Calcium-Binding Proteins; Carrier Proteins; Cell Line, Tumor; Endometrial Neoplasms; Female; Humans; Membrane Proteins; Mice; Mitochondrial Proteins; Nucleotides, Cyclic; Palmitoyl-CoA Hydrolase; Thymidine Monophosphate

2022